CVE-2021-2218
Summary
| CVE | CVE-2021-2218 |
|---|---|
| State | PUBLIC |
| Assigner | [email protected] |
| Source Priority | CVE Program / NVD first with legacy fallback |
| Published | 2021-04-22 22:15:00 UTC |
| Updated | 2021-04-26 18:15:00 UTC |
| Description | Vulnerability in the PeopleSoft Enterprise PT PeopleTools product of Oracle PeopleSoft (component: Health Center). Supported versions that are affected are 8.56 and 8.57. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise PeopleSoft Enterprise PT PeopleTools. While the vulnerability is in PeopleSoft Enterprise PT PeopleTools, attacks may significantly impact additional products. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of PeopleSoft Enterprise PT PeopleTools accessible data as well as unauthorized read access to a subset of PeopleSoft Enterprise PT PeopleTools accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of PeopleSoft Enterprise PT PeopleTools. CVSS 3.1 Base Score 8.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L). |
Risk And Classification
Problem Types: NVD-CWE-noinfo
NVD Known Affected Configurations (CPE 2.3)
| Type | Vendor | Product | Version | Update | Edition | Language |
|---|---|---|---|---|---|---|
| Application | Oracle | Peoplesoft Enterprise Pt Peopletools | 8.56 | All | All | All |
| Application | Oracle | Peoplesoft Enterprise Pt Peopletools | 8.57 | All | All | All |
References
| Reference | Source | Link | Tags |
|---|---|---|---|
| Oracle Critical Patch Update Advisory - April 2021 | MISC | www.oracle.com | |
| CVE Program record | CVE.ORG | www.cve.org | canonical |
| NVD vulnerability detail | NVD | nvd.nist.gov | canonical, analysis |
No vendor comments have been submitted for this CVE.
Legacy QID Mappings
- 375482 Oracle PeopleSoft Enterprise PeopleTools Product Multiple Vulnerabilities (CPUAPR2021)